Literature DB >> 8603869

Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom.

C H Yang1, T F Huang, K R Liu, M S Chen, P T Hung.   

Abstract

PURPOSE: Integrin-mediated extracellular matrix (ECM) attachment plays an important role in vitreous contraction of retinal pigment epithelial (RPE) cells. Disintegrins, a group of Arg-Gly-Asp (RGD)-containing peptides from viper venom, are potential anti-adhesion agents that interfere with integrin-ECM binding. This study was performed to determine whether disintegrins were effective in inhibiting RPE cell-induced matrix attachment in vitro and tractional retinal detachment in a rabbit model in vivo.
METHODS: Two disintegrins, echistatin from viper Echis carinatus and flavoridin from Trimeresurus flavoviridis, were used. The expression of integrins on the surface of bovine and rabbit RPE cells was examined by indirect immunofluorescent stain with specific anti-integrin monoclonal antibodies. The inhibitory effect of disintegrins on RPE cell-mediated ECM attachment and vitreous contraction was evaluated with cell adhesion and vitreous contraction assays. In the in vivo model, rabbit eyes were injected intravitreously with either homologous rabbit RPE cells alone or together with disintegrins to induce tractional retinal detachment. The cytotoxic effect of disintegrins was examined with a cell proliferation assay using the alamar blue method. Retinal toxicity of disintegrins was evaluated with electroretinograms and histologic examination of the rabbit eyes.
RESULTS: Bovine and rabbit RPE cells showed the positive staining for the integrins alpha 2 beta 1 and alpha 5 beta 1 on cell surface. Disintegrins, echistatin, and flavoridin inhibited RPE cell attachment to the ECM. The potency of disintegrins was 150 to 300 times higher than that of Gly-Arg-Gly-Asp-Ser (GRGDS) peptide. The disintegrins also inhibited RPE cell-induced vitreous contraction in a dose-dependent manner, whereas the GRGDS peptide had no effect. In the in vivo experiment, echistatin (50 microgram/ml) or flavoridin (80 microgram/ml) significantly inhibited RPE cell-induced tractional retinal detachment compared with the control group at week 2 (P< 0.05) and week 4 (P< 0.01) after surgery. Disintegrins were nontoxic to RPE cells and rabbit retina as evaluated by cytotoxicity tests, electroretinograms, and histologic examinations.
CONCLUSIONS: The disintegrins were effective in inhibiting RPE cell attachment to the ECM and vitreous contraction in vitro. They also were effective in suppressing RPE cell-induced tractional retinal detachment in the rabbit eyes. They were nontoxic. Disintegrins and their analogs might be potential anti-adhesion therapeutic agents in the treatment of proliferative vitreoretinopathy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8603869

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  A Novel Approach of Daunorubicin Application on Formation of Proliferative Retinopathy Using a Porous Silicon Controlled Delivery System: Pharmacodynamics.

Authors:  Huiyuan Hou; Kristyn Huffman; Sandy Rios; William R Freeman; Michael J Sailor; Lingyun Cheng
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-04       Impact factor: 4.799

2.  Osteopontin expression in vitreous and proliferative retinal membranes of patients with proliferative vitreous retinopathy.

Authors:  Xiao-Yi Liu; Lei Li; Jia-Qi Yao; Xi Chen; Qing-Huai Liu
Journal:  Int J Ophthalmol       Date:  2011-08-18       Impact factor: 1.779

3.  A selective cyclic integrin antagonist blocks the integrin receptors alphavbeta3 and alphavbeta5 and inhibits retinal pigment epithelium cell attachment, migration and invasion.

Authors:  Stephan Hoffmann; Shikun He; Manlin Jin; Marianne Ehren; Peter Wiedemann; Stephen J Ryan; David R Hinton
Journal:  BMC Ophthalmol       Date:  2005-06-29       Impact factor: 2.209

Review 4.  [Pharmacological approach to treatment of proliferative vitreoretinopathy].

Authors:  C S Priglinger; S Priglinger
Journal:  Ophthalmologe       Date:  2013-10       Impact factor: 1.059

Review 5.  An ocular view of the IGF-IGFBP system.

Authors:  Dung V Nguyen; Sergio Li Calzi; Lynn C Shaw; Jennifer L Kielczewski; Hannah E Korah; Maria B Grant
Journal:  Growth Horm IGF Res       Date:  2013-04-08       Impact factor: 2.372

6.  Enhanced generation of retinal progenitor cells from human retinal pigment epithelial cells induced by amniotic fluid.

Authors:  Fatemeh Sanie-Jahromi; Hamid Ahmadieh; Zahra-Soheila Soheili; Maliheh Davari; Shima Ghaderi; Mozhgan Rezaei Kanavi; Shahram Samiei; Abdolkhalegh Deezagi; Jalil Pakravesh; Abouzar Bagheri
Journal:  BMC Res Notes       Date:  2012-04-10

7.  Cell-mediated contraction of vitreous explants from chicken embryo: possibility of screening for therapeutic agents against proliferative vitreoretinal diseases.

Authors:  Keitaro Oki; Yoshiki Miyata; Arata Shimada; Terumasa Nagase; Yoshiya Katsura; Hiroshi Kosano
Journal:  Mol Vis       Date:  2013-11-23       Impact factor: 2.367

8.  In vitro vitamin K3 effect on conjunctival fibroblast migration and proliferation.

Authors:  I Pinilla; L B Izaguirre; F J Gonzalvo; E Piazuelo; M A Garcia-Gonzalez; A I Sanchez-Cano; F Sopeña
Journal:  ScientificWorldJournal       Date:  2014-01-08

9.  Amniotic fluid promotes the appearance of neural retinal progenitors and neurons in human RPE cell cultures.

Authors:  Maliheh Davari; Zahra-Soheila Soheili; Hamid Ahmadieh; Fateme Sanie-Jahromi; Shima Ghaderi; Mozhgan Rezaei Kanavi; Shahram Samiei; Hassan Akrami; Massoud Haghighi; Fahimeh Javidi-Azad
Journal:  Mol Vis       Date:  2013-11-17       Impact factor: 2.367

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.